News Summary

Noor Siddiqui, founder and CEO of biotech company Orchid, predicts a radical change in pregnancy through whole-genome sequencing of embryos for IVF. Speaking at the WIRED Health summit, Siddiqui highlighted that this technology could significantly reduce the risk of genetic diseases in children. Orchid’s screening analyzes DNA of embryos to lower the risk of genetic conditions, a method backed by investor and genomics pioneer George Church. This approach could mitigate risks of both monogenic and polygenic diseases, potentially impacting healthcare costs and family health outcomes.